Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9175 posts found.

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024 Research and Development AMR, Fleming Initiative, GSK, Microbiology, funding

GSK has announced that it has pledged £45m to the Fleming Initiative, becoming the first founding partner of the innovative …
News

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024 Research and Development NeuroSense, Neurology, als, clinical trials

NeuroSense has announced that it has partnered with PhaseV for its upcoming phase 3 trial of PrimeC as a treatment …
News

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024 Research and Development AstraZeneca, BenevolentAI, Cardiology, collaboration, heart failure

BenevolentAI has announced that AstraZeneca has added a novel heart failure target to its discovery portfolio following the two companies’ …
News

Fulcrum Therapeutics and Sanofi enter collaboration for facioscapulohumeral muscular dystrophy treatment

May 14, 2024 Research and Development Musculo-skeletal disorder, Sanofi, collaboration, fulcrum therapeutics, muscular dystrophy

Fulcrum Therapeutics has announced that it has entered into a collaboration and license agreement with Sanofi for the development and …
News
dementia image

Nxera Pharma partner Neurocrine Biosciences enters phase 1 NBI-1117567 study

May 9, 2024 Research and Development Alzheimer's disease, Neurocrine Biosciences, Neurology, Nxera Pharma, Parkinson's disease, clinical trials, dementia, schizophrenia

Nxera Pharma’s neuroscience-focused biopharmaceutical partner  Neurocrine Biosciences has announced it has successfully started its phase 1, first-in-human trial of investigational …
News

Mirum Pharmaceuticals publishes phase 3 MARCH maralixibat data in The Lancet

May 8, 2024 Research and Development Hepatology, Mirum Pharmaceuticals, PFIC, The Lancet, clinical trials

Biopharma company Mirum Pharmaceuticals has announced data from its phase 3 MARCH-PFIC study which evaluated maralixibat in patients with progressive …
News
biology-think-networking-physiology-brain-anatomy-2676370

Circular Genomics reveals study results into predicting patient response to SSRI antidepressant treatment

May 8, 2024 Research and Development Circular Genomics, Psychiatry, SSRI, antidepressant treatment, blood assays

US RNA biomarker company Circular Genomics has announced study results highlighting the company’s first blood assay to predict a patient’s …
News
lungs

Gossamer Bio and Chiesi Group enter into international collaboration to commercialise Seralutinib

May 7, 2024 Research and Development Chiesi, Chronic Diseases, Gossamer Bio, PAH, PH-ILD, collaboration

US-based clinical stage biopharma company Gossamer Bio and Italian research-focused biopharma group Chiesi Farmaceutici have entered into an international agreement …
News
trials

Broken String Biosciences and the Francis Crick Institute collaborate on ALS research

May 7, 2024 Research and Development Broken String Biosciences, Francis Crick Institute, Neurology, amyotrophic lateral sclerosis, genomics

Genomics company Broken String Biosciences and biomedical discovery institute Francis Crick have announced a research collaboration, focusing on amyotrophic lateral …
News

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024 Research and Development AbbVie, Pharmacy, R&D, facility

AbbVie has announced that it is investing approximately €150m in its second largest research and development (R&D) facility worldwide. The …
News

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024 Research and Development Gastric, MSD, Merck, Oncology, keytruda

Merck, known as MSD outside of the US and Canada, has announced data from the phase 3 KEYNOTE-811 trial which …
News

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024 Research and Development Obesity, Veru, Wegovy, enobosarm, weight loss

Veru has announced that it has enrolled the first patients into its phase 2b clinical trial of enobosarm, an oral …
News

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024 Research and Development Bayer, Cardiology, cardio, cvd

Bayer and Evotec have announced that they have updated the focus of their collaboration to work on the development of …
News

PeptiDream and Novartis extend peptide discovery collaboration

April 30, 2024 Research and Development Novartis, PeptiDream, Pharmacy, collaboration, drug discovery, peptides

PeptiDream has announced the expansion of its peptide discovery collaboration with Novartis Pharma AG.
News

Regeneron and Mammoth Biosciences announce CRISPR collaboration

April 26, 2024 Research and Development Pharmacy, Regeneron, crispr, gene editing

Regeneron Pharmaceuticals and Mammoth Biosciences have announced a collaboration for the research, development and commercialisation of in vivo CRISPR-based gene …
News

Latest content

FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer

May 17, 2024

AstraZeneca shares results from phase 3 trial of COVID-19 prevention drug

May 17, 2024

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024